Opus Genetics, Inc. earnings per share and revenue

IRD earnings per share for the last quarter are -0.30 USD whereas the estimation was -0.26 USD which accounts for -17.65% surprise. Company revenue for the same period amounts to 1.11 M USD despite the estimated figure of 2.45 M USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 2.28 M USD. Also watch annual changes over time to get a bigger picture of IRD earnings per share and revenue dynamics.